The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global LFA-based Cardiac Marker Market Research Report 2025
Synopsis
The global LFA-based Cardiac Marker market was valued at US$ 3595.4 million in 2023 and is anticipated to reach US$ 4620 million by 2030, witnessing a CAGR of 3.7% during the forecast period 2024-2030.
North American market for LFA-based Cardiac Marker is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for LFA-based Cardiac Marker is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for LFA-based Cardiac Marker in Laboratory Testing is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of LFA-based Cardiac Marker include Thermo Fisher, Bio-Rad Laboratories, Becton, Dickinson, Roche, Hologic, Abbott, Siemens, Danaher and Alere, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for LFA-based Cardiac Marker, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding LFA-based Cardiac Marker.
Report Scope
The LFA-based Cardiac Marker market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global LFA-based Cardiac Marker market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the LFA-based Cardiac Marker companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher
Bio-Rad Laboratories
Becton, Dickinson
Roche
Hologic
Abbott
Siemens
Danaher
Alere
BioMérieux
LSI
Clinical Diagnostics
Randox laboratories
Wondfo Biotech
Segment by Type
Troponin
CK-MB
Myoglobin
Others
Segment by Application
Laboratory Testing
Point-of-care Testing
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of LFA-based Cardiac Marker companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global LFA-based Cardiac Marker market was valued at US$ 3595.4 million in 2023 and is anticipated to reach US$ 4620 million by 2030, witnessing a CAGR of 3.7% during the forecast period 2024-2030.
North American market for LFA-based Cardiac Marker is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for LFA-based Cardiac Marker is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for LFA-based Cardiac Marker in Laboratory Testing is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of LFA-based Cardiac Marker include Thermo Fisher, Bio-Rad Laboratories, Becton, Dickinson, Roche, Hologic, Abbott, Siemens, Danaher and Alere, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for LFA-based Cardiac Marker, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding LFA-based Cardiac Marker.
Report Scope
The LFA-based Cardiac Marker market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global LFA-based Cardiac Marker market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the LFA-based Cardiac Marker companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher
Bio-Rad Laboratories
Becton, Dickinson
Roche
Hologic
Abbott
Siemens
Danaher
Alere
BioMérieux
LSI
Clinical Diagnostics
Randox laboratories
Wondfo Biotech
Segment by Type
Troponin
CK-MB
Myoglobin
Others
Segment by Application
Laboratory Testing
Point-of-care Testing
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of LFA-based Cardiac Marker companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global LFA-based Cardiac Marker Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Troponin
1.2.3 CK-MB
1.2.4 Myoglobin
1.2.5 Others
1.3 Market by Application
1.3.1 Global LFA-based Cardiac Marker Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Laboratory Testing
1.3.3 Point-of-care Testing
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global LFA-based Cardiac Marker Market Perspective (2019-2030)
2.2 LFA-based Cardiac Marker Growth Trends by Region
2.2.1 Global LFA-based Cardiac Marker Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 LFA-based Cardiac Marker Historic Market Size by Region (2019-2024)
2.2.3 LFA-based Cardiac Marker Forecasted Market Size by Region (2025-2030)
2.3 LFA-based Cardiac Marker Market Dynamics
2.3.1 LFA-based Cardiac Marker Industry Trends
2.3.2 LFA-based Cardiac Marker Market Drivers
2.3.3 LFA-based Cardiac Marker Market Challenges
2.3.4 LFA-based Cardiac Marker Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top LFA-based Cardiac Marker Players by Revenue
3.1.1 Global Top LFA-based Cardiac Marker Players by Revenue (2019-2024)
3.1.2 Global LFA-based Cardiac Marker Revenue Market Share by Players (2019-2024)
3.2 Global LFA-based Cardiac Marker Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by LFA-based Cardiac Marker Revenue
3.4 Global LFA-based Cardiac Marker Market Concentration Ratio
3.4.1 Global LFA-based Cardiac Marker Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by LFA-based Cardiac Marker Revenue in 2023
3.5 LFA-based Cardiac Marker Key Players Head office and Area Served
3.6 Key Players LFA-based Cardiac Marker Product Solution and Service
3.7 Date of Enter into LFA-based Cardiac Marker Market
3.8 Mergers & Acquisitions, Expansion Plans
4 LFA-based Cardiac Marker Breakdown Data by Type
4.1 Global LFA-based Cardiac Marker Historic Market Size by Type (2019-2024)
4.2 Global LFA-based Cardiac Marker Forecasted Market Size by Type (2025-2030)
5 LFA-based Cardiac Marker Breakdown Data by Application
5.1 Global LFA-based Cardiac Marker Historic Market Size by Application (2019-2024)
5.2 Global LFA-based Cardiac Marker Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America LFA-based Cardiac Marker Market Size (2019-2030)
6.2 North America LFA-based Cardiac Marker Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America LFA-based Cardiac Marker Market Size by Country (2019-2024)
6.4 North America LFA-based Cardiac Marker Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe LFA-based Cardiac Marker Market Size (2019-2030)
7.2 Europe LFA-based Cardiac Marker Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe LFA-based Cardiac Marker Market Size by Country (2019-2024)
7.4 Europe LFA-based Cardiac Marker Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific LFA-based Cardiac Marker Market Size (2019-2030)
8.2 Asia-Pacific LFA-based Cardiac Marker Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific LFA-based Cardiac Marker Market Size by Region (2019-2024)
8.4 Asia-Pacific LFA-based Cardiac Marker Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America LFA-based Cardiac Marker Market Size (2019-2030)
9.2 Latin America LFA-based Cardiac Marker Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America LFA-based Cardiac Marker Market Size by Country (2019-2024)
9.4 Latin America LFA-based Cardiac Marker Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa LFA-based Cardiac Marker Market Size (2019-2030)
10.2 Middle East & Africa LFA-based Cardiac Marker Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa LFA-based Cardiac Marker Market Size by Country (2019-2024)
10.4 Middle East & Africa LFA-based Cardiac Marker Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher
11.1.1 Thermo Fisher Company Detail
11.1.2 Thermo Fisher Business Overview
11.1.3 Thermo Fisher LFA-based Cardiac Marker Introduction
11.1.4 Thermo Fisher Revenue in LFA-based Cardiac Marker Business (2019-2024)
11.1.5 Thermo Fisher Recent Development
11.2 Bio-Rad Laboratories
11.2.1 Bio-Rad Laboratories Company Detail
11.2.2 Bio-Rad Laboratories Business Overview
11.2.3 Bio-Rad Laboratories LFA-based Cardiac Marker Introduction
11.2.4 Bio-Rad Laboratories Revenue in LFA-based Cardiac Marker Business (2019-2024)
11.2.5 Bio-Rad Laboratories Recent Development
11.3 Becton, Dickinson
11.3.1 Becton, Dickinson Company Detail
11.3.2 Becton, Dickinson Business Overview
11.3.3 Becton, Dickinson LFA-based Cardiac Marker Introduction
11.3.4 Becton, Dickinson Revenue in LFA-based Cardiac Marker Business (2019-2024)
11.3.5 Becton, Dickinson Recent Development
11.4 Roche
11.4.1 Roche Company Detail
11.4.2 Roche Business Overview
11.4.3 Roche LFA-based Cardiac Marker Introduction
11.4.4 Roche Revenue in LFA-based Cardiac Marker Business (2019-2024)
11.4.5 Roche Recent Development
11.5 Hologic
11.5.1 Hologic Company Detail
11.5.2 Hologic Business Overview
11.5.3 Hologic LFA-based Cardiac Marker Introduction
11.5.4 Hologic Revenue in LFA-based Cardiac Marker Business (2019-2024)
11.5.5 Hologic Recent Development
11.6 Abbott
11.6.1 Abbott Company Detail
11.6.2 Abbott Business Overview
11.6.3 Abbott LFA-based Cardiac Marker Introduction
11.6.4 Abbott Revenue in LFA-based Cardiac Marker Business (2019-2024)
11.6.5 Abbott Recent Development
11.7 Siemens
11.7.1 Siemens Company Detail
11.7.2 Siemens Business Overview
11.7.3 Siemens LFA-based Cardiac Marker Introduction
11.7.4 Siemens Revenue in LFA-based Cardiac Marker Business (2019-2024)
11.7.5 Siemens Recent Development
11.8 Danaher
11.8.1 Danaher Company Detail
11.8.2 Danaher Business Overview
11.8.3 Danaher LFA-based Cardiac Marker Introduction
11.8.4 Danaher Revenue in LFA-based Cardiac Marker Business (2019-2024)
11.8.5 Danaher Recent Development
11.9 Alere
11.9.1 Alere Company Detail
11.9.2 Alere Business Overview
11.9.3 Alere LFA-based Cardiac Marker Introduction
11.9.4 Alere Revenue in LFA-based Cardiac Marker Business (2019-2024)
11.9.5 Alere Recent Development
11.10 BioMérieux
11.10.1 BioMérieux Company Detail
11.10.2 BioMérieux Business Overview
11.10.3 BioMérieux LFA-based Cardiac Marker Introduction
11.10.4 BioMérieux Revenue in LFA-based Cardiac Marker Business (2019-2024)
11.10.5 BioMérieux Recent Development
11.11 LSI
11.11.1 LSI Company Detail
11.11.2 LSI Business Overview
11.11.3 LSI LFA-based Cardiac Marker Introduction
11.11.4 LSI Revenue in LFA-based Cardiac Marker Business (2019-2024)
11.11.5 LSI Recent Development
11.12 Clinical Diagnostics
11.12.1 Clinical Diagnostics Company Detail
11.12.2 Clinical Diagnostics Business Overview
11.12.3 Clinical Diagnostics LFA-based Cardiac Marker Introduction
11.12.4 Clinical Diagnostics Revenue in LFA-based Cardiac Marker Business (2019-2024)
11.12.5 Clinical Diagnostics Recent Development
11.13 Randox laboratories
11.13.1 Randox laboratories Company Detail
11.13.2 Randox laboratories Business Overview
11.13.3 Randox laboratories LFA-based Cardiac Marker Introduction
11.13.4 Randox laboratories Revenue in LFA-based Cardiac Marker Business (2019-2024)
11.13.5 Randox laboratories Recent Development
11.14 Wondfo Biotech
11.14.1 Wondfo Biotech Company Detail
11.14.2 Wondfo Biotech Business Overview
11.14.3 Wondfo Biotech LFA-based Cardiac Marker Introduction
11.14.4 Wondfo Biotech Revenue in LFA-based Cardiac Marker Business (2019-2024)
11.14.5 Wondfo Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
